iBio Inc [NASDAQ: IBIO] jumped around 1119999.23 points on Monday, while shares priced at $1120000.0 at the close of the session, up 8031528%.
Compared to the average trading volume of 1.12M shares, IBIO reached a trading volume of 8031528 in the most recent trading day, which is why market watchdogs consider the stock to be active.
What do top market gurus say about iBio Inc [IBIO]?
Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for IBIO shares is $5.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on IBIO stock is a recommendation set at 1.00. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.
Chardan Capital Markets have made an estimate for iBio Inc shares, keeping their opinion on the stock as Buy, with their previous recommendation back on May 28, 2024. While these analysts kept the previous recommendation, JMP Securities raised their target price to Mkt Outperform. The new note on the price target was released on November 29, 2021, representing the official price target for iBio Inc stock. Previously, the target price had yet another raise to $3, while Cantor Fitzgerald analysts kept a Overweight rating on IBIO stock.
The Price to Book ratio for the last quarter was 0.63, with the Price to Cash per share for the same quarter was set at 0.31.
How has IBIO stock performed recently?
iBio Inc [IBIO] fell into the red zone at the end of the last week, falling into a negative trend and dropping by -23.24. With this latest performance, IBIO shares dropped by -7.53% in over the last four-week period, additionally sinking by -70.56% over the last 6 months – not to mention a drop of -70.92% in the past year of trading.
iBio Inc [IBIO]: Deeper insight into the fundamentals
Operating Margin for any stock indicates how profitable investing would be, and iBio Inc [IBIO] shares currently have an operating margin of -4483.47% and a Gross Margin at -199.20%. iBio Inc’s Net Margin is presently recorded at -5597.87%.
Return on Equity for this stock declined to -47.53%, with Return on Assets sitting at -47.53%.
Insider trade positions for iBio Inc [IBIO]
The top three institutional holders of IBIO stocks are: LYNX1 CAPITAL MANAGEMENT LP with ownership of 0.6 million shares, which is approximately 6.9576%. IKARIAN CAPITAL, LLC, holding 0.6 million shares of the stock with an approximate value of $$1.27 million in IBIO stocks shares; and IKARIAN CAPITAL, LLC, currently with $$1.2 million in IBIO stock with ownership which is approximately 6.6097%.
